Highlights Prenetics Global Limited

Equities

PRE

KYG722451229

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-30 pm EDT			5-day change	1st Jan Change
5.05 ^USD	+13.48%		+10.50%	-14.55%

Apr. 01	Prenetics Global Limited Reports Impairment Loss of Goodwill for the Fourth Quarter Ended December 31, 2023	CI
Apr. 01	Prenetics Global Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Prenetics Global Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
Prenetics Global Limited Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Apr. 01	CI
Earnings Flash (PRE) PRENETICS LIMITED Reports Q4 Revenue $5.4M	Apr. 01	MT
Earnings Flash (PRE) PRENETICS LIMITED Reports Q3 Revenue $4.9M	Nov. 20	MT
Prenetics Global Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 20	CI
Earnings Flash (PRE) PRENETICS LIMITED Reports Q2 Revenue $5.7M	23-09-15	MT
Prenetics Global Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-09-15	CI
Prenetics Global Forms JV With Hong Kong University Professor for Multi-Cancer Early Detection Screening	23-06-26	MT
Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establishes USD 200 Million Joint Venture Insighta for Breakthrough Multi-Cancer Early Detection Screening	23-06-25	CI
Earnings Flash (PRE) PRENETICS LIMITED Reports Q1 Revenue $17.7M	23-06-05	MT
Prenetics Global Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	23-06-05	CI
Prenetics Global : UPDATE - Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results	23-05-01	PU
Tranche Update on Prenetics Global Limited's Equity Buyback Plan announced on November 30, 2022.	23-05-01	CI
Tranche Update on Prenetics Global Limited's Equity Buyback Plan announced on November 30, 2022.	23-05-01	CI
Prenetics Global Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-14	CI
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results, New Business Strategy Focused on Precision Oncology	23-03-14	AQ
Earnings Flash (PRE) PRENETICS LIMITED Reports Q4 Revenue $52.3M	23-03-14	MT
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results	23-03-14	GL
Prenetics Global Limited Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-03-14	CI
Prenetics Says ACT Genomics Receives US FDA Clearance for Genomic Profiling Test for All Solid Tumors	23-01-10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Prenetics Global Limited

Equities

PRE

KYG722451229

Highlights

Filters